FDA — authorised 19 December 1997
- Application: NDA020686
- Marketing authorisation holder: BRACCO
- Local brand name: LUMENHANCE
- Indication: FOR SOLUTION — ORAL
- Status: approved
🇺🇸 LUMENHANCE in United States
FDA authorised LUMENHANCE on 19 December 1997
Marketing authorisations
FDA
- Status: approved
LUMENHANCE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is LUMENHANCE approved in United States?
Yes. FDA authorised it on 19 December 1997; FDA has authorised it.
Who is the marketing authorisation holder for LUMENHANCE in United States?
BRACCO holds the US marketing authorisation.